Wedbush Securities’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,297
Closed -$63K 1277
2025
Q4
$63K Hold
10,297
﹤0.01% 1187
2025
Q3
$53K Hold
10,297
﹤0.01% 1153
2025
Q2
$61K Hold
10,297
﹤0.01% 1133
2025
Q1
$85K Buy
+10,297
New +$86.4K ﹤0.01% 1071
2023
Q2
Sell
-11,776
Closed -$138K 1110
2023
Q1
$138K Sell
11,776
-2,993
-20% -$43.7K 0.01% 991
2022
Q4
$249K Buy
14,769
+420
+3% +$6.93K 0.01% 814
2022
Q3
$168K Sell
14,349
-164
-1% -$2.34K 0.01% 920
2022
Q2
$229K Buy
+14,513
New +$244K 0.01% 873

Other funds holding PTEN

Wedbush Securities's PTEN Position: Q1 2026 in Review

Wedbush Securities sold out of Patterson-UTI (PTEN) in Q1 2026, closing a stake of 10,297 shares — an estimated $63K sold.

Wedbush Securities first reported a position in PTEN in Q2 2022 and held it in 8 quarters. The position peaked at $249K in Q4 2022. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Wedbush Securities reported no remaining Patterson-UTI position as of Q1 2026 after selling out during the quarter.
  • Wedbush Securities sold 10,297 Patterson-UTI shares in Q1 2026, an estimated $63K.
  • Wedbush Securities first reported a position in Patterson-UTI in Q2 2022 and held it in 8 quarters.
  • Wedbush Securities's Patterson-UTI position peaked at $249K in Q4 2022.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.